03
Apr
By Floris ten Have | Senior Associate | Amsterdam | Stibbe
On 7 March 2018, the president of the Dutch Authority for Consumers and Markets (ACM) together with two colleagues published a paper concerning the application of the competition rules in the pharmaceutical industry.
The paper specifically explains that they see a role for competition law enforcement if the owners of patented drugs engage in excessive pricing. In its agenda 2018-2019 publishedearlier this year, the ACM indicated that it will focus on four topics, one of...